French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge-Reference-Cited by-同舟云学术

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge

Published:2021-07 Issue:4 Volume:76 Page:297-303
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Lacroix Clémence,Salvo Francesco,Gras-Champel Valérie,Gautier Sophie,Massy Nathalie,Valnet-Rabier Marie-Blanche,Grandvuillemin Aurélie,Mounier Céline,Benkebil Mehdi,Pariente Antoine,Jonville-Béra Annie-Pierre,Micallef Joëlle

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference21 articles.

1. European Medicines Agency (EMA)–Science Medicines Health,2021

2. U.S Food and Drug Administration (FDA),2021

3. Uppsala Monitoring Centre–VigiBa,2021

4. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France;Dauvilliers;Brain,2013

5. Avis relatif aux caractéristiques des futurs vaccins pandémiques;Haut Conseil de la Santé Publique,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France;Drug Safety;2023-11-05

2. Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective;Therapies;2023-09

3. Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!;Therapies;2023-09

4. Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?;Therapies;2023-09

5. Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic;Therapies;2023-09